amounts anticipated if at all; that either Chinese
Governmental approval processes regarding our product registrations or U.S.
and German government-backed loan projects will be successfully completed
or lead to profitable product sales; nor that the medical products division
will return to profitability in the current year. Forward-looking
statements may be identified by terms such as "may", "will", "should",
"could", "expects", "plans", "intends", "anticipates", "believes",
"estimates", "predicts", "forecasts", "potential", or "continue" or similar
terms or the negative of these terms. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or
achievements. We have no obligation to update these forward-looking
statements
For more information, please contact:
Judy Zakreski or Lawrence Pemble
Tel: +1-301-215-7777
'/>"/>SOURCE Chindex International, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.2.
Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement3.
Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference4.
Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 20085.
Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 20086.
Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference7.
The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank8.
International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers9.
Arrow International Files and Mails Definitive Proxy Materials10.
Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software11.
DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)